Freenome's SimpleScreen CRC, a blood-based colorectal cancer screening test, received FDA approval and will be commercialized in the U.S. by Abbott to help millions of Americans who are overdue for screening.
Freenome's SimpleScreen CRC, a blood-based colorectal cancer screening test, received FDA approval and will be commercialized in the U.S. by Abbott to help millions of Americans who are overdue for screening.